|
University of California, San Francisco |
Mitchel Berger |
Disease Team Research I |
Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM) |
$19,162,435 |
|
University of Southern California |
Mark Humayun |
Disease Team Research I |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$18,904,916 |
|
University of California, San Diego |
Lawrence Goldstein |
Disease Team Research I |
Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis |
$10,857,762 |
|
Calimmune, Inc. |
Geoff Symonds |
Disease Team Research I |
GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE |
$8,278,722 |
|
University of California, Los Angeles |
Irvin Chen |
Early Translational from Disease Team Conversion |
HPSC based therapy for HIV disease using RNAi to CCR5. |
$1,505,000 |
|
University of California, San Diego |
Dennis Carson |
Disease Team Research I |
Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) |
$19,999,826 |
|
Stanford University |
Alfred Lane |
Disease Team Research I |
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa |
$11,709,574 |
|
Beckman Research Institute of City of Hope |
Karen Aboody |
Disease Team Research I |
Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials |
$18,015,429 |
|
Stanford University |
Gary Steinberg |
Disease Team Research I |
Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke |
$20,000,000 |
|
University of California, Los Angeles |
Dennis Slamon |
Disease Team Research I |
THERAPEUTIC OPPORTUNITIES TO TARGET TUMOR INITIATING CELLS IN SOLID TUMORS |
$19,979,660 |
|
University of California, Los Angeles |
Donald Kohn |
Disease Team Research I |
Stem Cell Gene Therapy for Sickle Cell Disease |
$9,212,365 |
|
Stanford University |
Irving Weissman |
Disease Team Research I |
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells |
$19,999,996 |
|
ViaCyte, Inc. |
Allan Robins |
Disease Team Research I |
Cell Therapy for Diabetes |
$22,999,937 |
|
Cedars-Sinai Medical Center |
Eduardo Marbán |
Disease Team Research I |
Autologous cardiac-derived cells for advanced ischemic cardiomyopathy |
$5,560,232 |
|
Beckman Research Institute of City of Hope |
John Zaia |
Disease Team Research I |
ZIinc Finger Nuclease-Based Stem Cell Therapy for AIDS |
$14,583,187 |
|
University of California, Los Angeles |
Irvin Chen |
Disease Team Research I |
HPSC based therapy for HIV disease using RNAi to CCR5. |
$9,905,604 |
|
Beckman Research Institute of City of Hope |
Michael Barish |
Research Training II |
Research Training Program in Stem Cell Biology |
$2,500,143 |
|
Scripps Research Institute |
Jeanne Loring |
Shared Labs |
Center for hESC Research |
$3,828,751 |
|
Stanford University |
Renee Reijo Pera |
Shared Labs |
Center for Human Embryonic Stem Cell Research and Education |
$5,819,047 |
|
University of California, Los Angeles |
Stanley Nelson |
Disease Team Therapy Development - Research |
Combination Therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$6,000,000 |
|
University of California, San Diego |
Karl Willert |
Shared Labs |
Enhancing Facilities for Genetic Manipulation and Engineering of Human Embryonic Stem Cells |
$3,711,102 |
|
Stanford University |
Judith Shizuru |
Disease Team Therapy Development - Research |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$20,000,000 |
|
Buck Institute for Age Research |
Xianmin Zeng |
Shared Labs |
CIRM Shared Research Laboratory for Stem Cells and Aging |
$5,883,026 |
|
University of California, Los Angeles |
Antoni Ribas |
Disease Team Therapy Development - Research |
Genetic Re-programming of Stem Cells to Fight Cancer |
$19,999,563 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Shared Labs |
CIRM Shared Human Embryonic Stem Cell Core Laboratory |
$2,621,345 |
|
Children's Hospital of Los Angeles |
David Warburton |
Research Training II |
Stem Cell Training Grant |
$5,103,441 |
|
University of California, Davis |
Nancy Lane |
Disease Team Therapy Development - Research |
Treatment of osteoporosis with endogenous Mesenchymal stem cells |
$19,999,867 |
|
University of California, Santa Cruz |
Lindsay Hinck |
Shared Labs |
Shared Stem Cell Facility |
$3,588,740 |
|
The J. David Gladstone Institutes |
Robert Mahley |
Research Training II |
CIRM Scholars Program |
$5,111,047 |
|
University of California, Davis |
John Laird |
Disease Team Therapy Development - Research |
Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia |
$14,184,595 |
|
University of California, Los Angeles |
Owen Witte |
Shared Labs |
CIRM Shared Research Laboratories |
$3,740,497 |
|
University of California, Berkeley |
Ellen Robey |
Research Training II |
Interdisciplinary Training in Stem Cell Biology, Engineering and Medicine |
$6,902,189 |
|
University of California, Davis |
Vicki Wheelock |
Disease Team Therapy Development - Research |
MSC engineered to produce BDNF for the treatment of Huntington's disease |
$18,950,061 |
|
The Salk Institute for Biological Studies |
Inder Verma |
Shared Labs |
Shared viral vector facility for genetic manipulation of human ES cell |
$4,316,515 |
|
Scripps Research Institute |
Ulrich Mueller |
Research Training II |
Training Stem Cell Researchers at the Chemistry-Biology Interface |
$4,058,362 |
|
Cedars-Sinai Medical Center |
Clive Svendsen |
Disease Team Therapy Development - Research |
Progenitor Cells Secreting GDNF for the Treatment of ALS |
$17,842,617 |
|
University of California, Irvine |
Peter Donovan |
Shared Labs |
Regional Human Embryonic Stem Cell Shared Research Laboratory and Stem Cell Techniques Course |
$5,572,979 |
|
University of California, Irvine |
Peter Donovan |
Research Training II |
Research Training Program II |
$6,827,148 |
|
StemCells, Inc. |
Alexandra Capela |
Disease Team Therapy Development - Research |
Restoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy |
$20,000,000 |
|
Children's Hospital of Los Angeles |
David Warburton |
Shared Labs |
hESC Facility |
$3,756,666 |
|
University of California, San Francisco |
Susan Fisher |
Research Training II |
Training Program in Stem Cell Research |
$7,946,605 |
|
StemCells, Inc. |
Nobuko Uchida |
Disease Team Therapy Development - Research |
Neural stem cell transplantation for chronic cervical spinal cord injury |
$20,000,000 |
|
University of Southern California |
Andrew McMahon |
Shared Labs |
Center for Stem Cell and Regenerative Medicine: Shared Research Laboratory and Course in Current Protocols in Human Embryonic Stem Cell Research |
$5,355,969 |
|
University of California, San Diego |
Sylvia Evans |
Research Training II |
Interdisciplinary Stem Cell Training Program |
$7,890,588 |
|
University of California, Irvine |
Henry Klassen |
Disease Team Therapy Development - Research |
Retinal progenitor cells for treatment of retinitis pigmentosa |
$17,306,668 |
|
University of California, San Francisco |
Linda Giudice |
Shared Labs |
Shared Research and Teaching Laboratory: a Non-Federal Human Embryonic Stem Cell Resource for the Bay Area Community |
$5,546,877 |
|
University of California, Santa Cruz |
David Haussler |
Research Training II |
CIRM Training Program in Systems Biology of Stem cells |
$4,591,616 |
|
Capricor, Inc |
Rachel Smith |
Disease Team Therapy Development - Research |
Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction |
$19,782,136 |
|
University of California, Santa Barbara |
Dennis Clegg |
Shared Labs |
Laboratory for Stem Cell Biology and Engineering |
$3,161,329 |
|
The Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Research Training II |
Training in the Biology of Human Embryonic Stem Cells and Emerging Technologies II |
$3,062,677 |
|
University of California, Davis |
Alice Tarantal |
Shared Labs |
Translational Human Embryonic Stem Cell Shared Research Facility |
$3,709,631 |
|
University of California, Santa Barbara |
Dennis Clegg |
Research Training II |
Training Program in Stem Cell Biology and Engineering |
$2,451,273 |
|
University of California, Berkeley |
David Schaffer |
Shared Labs |
Human Embryonic Stem Cell Shared Research Laboratory |
$2,929,237 |
|
Stanford University |
Renee Reijo Pera |
Research Training II |
CIRM Training Program |
$7,974,291 |
|
University of California, Riverside |
Prudence Talbot |
Shared Labs |
A Stem Cell Core Facility for Studying Human Embryonic Stem Cell Differentiation |
$3,658,353 |
|
Buck Institute for Age Research |
David Greenberg |
Research Training II |
CIRM Research Training Program in Stem Cells and Aging |
$3,178,692 |
|
Sanford-Burnham Medical Research Institute |
Evan Snyder |
Shared Labs |
Collaborative Laboratory for Human Embryonic Stem Cell Research |
$4,762,725 |
|
University of Southern California |
Robert Maxson |
Research Training II |
CIRM Stem Cell Biology Training Program |
$6,162,053 |
|
Stanford University |
Joseph Wu |
Disease Team Therapy Development - Research |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$19,999,899 |
|
Sanford-Burnham Medical Research Institute |
Mark Mercola |
Research Training II |
Type III CIRM Stem Cell Research Training Program |
$2,856,694 |
|
University of California, Davis |
Frederick Meyers |
Research Training II |
Stem Cell Training Program |
$7,358,024 |
|
University of California, Los Angeles |
Kenneth Dorshkind |
Research Training II |
CIRM Research Training Program II |
$7,982,293 |
|
Beckman Research Institute of City of Hope |
Yanhong Shi |
Basic Biology IV |
Modeling Alexander disease using patient-specific induced pluripotent stem cells |
$1,367,172 |
|
University of California, Los Angeles |
Kathrin Plath |
Basic Biology IV |
Understanding the status of the X chromosomes in human ESCs and preimplantation embryos |
$1,382,400 |
|
University of California, San Diego |
Maike Sander |
Basic Biology IV |
Deciphering transcriptional control of pancreatic beta-cell maturation in vitro |
$1,391,400 |
|
The J. David Gladstone Institutes |
Sheng Ding |
Basic Biology IV |
A new paradigm of lineage-specific reprogramming |
$1,708,560 |
|
Sanford-Burnham Medical Research Institute |
Huei-sheng Chen |
Basic Biology IV |
Studying Arrhythmogenic Right Ventricular Dysplasia with patient-specific iPS cells |
$1,582,606 |
|
University of California, Los Angeles |
Owen Witte |
Basic Biology IV |
Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells |
$1,382,400 |
|
Stanford University |
Howard Chang |
Basic Biology IV |
Long noncoding RNAs for pluripotency and cell fate commitment |
$1,386,627 |
|
University of California, San Diego |
David Traver |
Basic Biology IV |
DECIPHERING THE INSTRUCTIONS FOR VERTEBRATE HSC SPECIFICATION AND AMPLIFICATION. |
$1,363,698 |
|
The J. David Gladstone Institutes |
Steven Finkbeiner |
Basic Biology IV |
Common molecular mechanisms in neurodegenerative diseases using patient based iPSC neurons |
$1,506,420 |
|
Stanford University |
Michelle Monje |
Basic Biology IV |
Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain |
$1,264,248 |
|
The J. David Gladstone Institutes |
Benoit Bruneau |
Basic Biology IV |
Epigenetic regulation of human cardiac differentiation |
$1,708,560 |
|
Cedars-Sinai Medical Center |
Eduardo Marbán |
Basic Biology IV |
Mechanism of heart regeneration by cardiosphere-derived cells |
$1,367,604 |
|
University of California, San Diego |
Miles Wilkinson |
Basic Biology IV |
Role of the NMD RNA Decay Pathway in Maintaining the Stem-Like State |
$1,360,450 |
|
Stanford University |
Ben Barres |
Basic Biology IV |
Phenotyping Human Astrocytes in Health and Disease |
$1,385,517 |
|
Stanford University |
Gerald Crabtree |
Basic Biology IV |
Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch |
$1,392,426 |
|
University of California, San Diego |
Ananda Goldrath |
Basic Biology IV |
Mechanisms to protect hESC-derived cells from allogenic immune rejection |
$1,161,000 |
|
Stanford University |
Roel Nusse |
Basic Biology IV |
Asymmetric stem cell division oriented by a local self-renewing signal |
$1,195,811 |
|
University of California, San Diego |
Eugene Yeo |
Basic Biology IV |
Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration |
$1,393,200 |
|
University of California, San Francisco |
Barbara Panning |
Basic Biology IV |
Investigation of the role of O-GlcNAcylation in SOX2 function during reprogramming |
$1,285,214 |
|
University of California, Berkeley |
Robert Tjian |
Basic Biology IV |
Transcriptional regulation of pluripotency in human embryonic stem cells |
$1,220,968 |
|
Stanford University |
Anne Brunet |
Basic Biology IV |
Energy metabolism and aging pathways in human stem cell reprogramming and differentiation |
$1,414,044 |
|
Stanford University |
Michael Cleary |
Basic Biology IV |
Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells |
$1,244,455 |
|
University of California, Davis |
Deborah Lieu |
Basic Biology IV |
Induction of Pluripotent Stem Cell-Derived Pacemaking Cells |
$1,334,880 |
|
University of California, San Francisco |
Miguel Ramalho-Santos |
Basic Biology IV |
Genetic dissection of human cellular reprogramming to pluripotency |
$1,184,883 |
|
Buck Institute for Age Research |
Deepak Lamba |
Basic Biology IV |
3D Modeling of Retina using Polymer Scaffolds for Understanding Disease Pathogenesis |
$1,526,319 |
|
University of California, San Francisco |
Jeremy Reiter |
Basic Biology IV |
Modeling disease in human embryonic stem cells using new genetic tools |
$1,387,800 |
|
Stanford University |
Alexander Dunn |
Basic Biology IV |
Role of mechanical signaling in stem cell self-renewal and differentiation |
$1,064,224 |
|
University of California, San Diego |
George Sen |
Basic Biology IV |
Regulation of Epidermal Self-Renewal and Differentiation by Histone and DNA Demethylases.
|
$1,080,000 |
|
University of California, San Francisco |
Ophir Klein |
New Faculty II |
Laying the groundwork for building a tooth: analysis of dental epithelial stem cells |
$3,250,251 |
|
University of California, San Francisco |
Emmanuelle Passegue |
New Faculty II |
Mechanisms Underlying the Responses of Normal and Cancer Stem Cells to Environmental and Therapeutic Insults |
$2,274,368 |
|
University of Southern California |
Qilong Ying |
New Faculty II |
Mechanisms Underlying the Diverse Functions of STAT3 in Embryonic Stem Cell Fate Regulation |
$2,413,650 |
|
University of California, Los Angeles |
Antoni Ribas |
New Faculty II |
Stem Cells for Immune System Regeneration to Fight Cancer |
$3,247,000 |
|
San Diego State University |
Ricardo Zayas |
New Faculty II |
The molecular basis underlying adult neurogenesis during regeneration and tissue renewal |
$1,725,830 |
|
The J. David Gladstone Institutes |
Benoit Bruneau |
New Faculty II |
Induction of cardiogenesis in pluripotent cells via chromatin remodeling factors |
$2,847,600 |
|
University of California, Los Angeles |
Brigitte Gomperts |
New Faculty II |
Stem Cells in Lung Cancer |
$2,556,572 |
|
Ludwig Institute for Cancer Research |
Bing Ren |
New Faculty II |
Mechanisms of chromatin dynamics at enhancers during ES cell differentiation |
$1,726,564 |
|
University of California, San Diego |
Shyni Varghese |
New Faculty II |
A Novel Microenvironment-Mediated Functional Skeletal Muscle from Human Embryonic Stem Cells and their In Vivo Engraftment |
$2,300,569 |
|
University of California, San Francisco |
Robert Blelloch |
New Faculty II |
Mechanisms of small RNA regulation in early embryonic development |
$3,204,897 |